Skip to content

Agenda - Wednesday 30 October 2019

Choose relevant sessions for you in your role:

  • MDT Icon Square

    Multi-disciplinary team – these sessions are suitable for the entire MDT and will aim to promote joint working and understanding of care pathways.

  • PCNS Icon Square

    Primary Care & Non-Specialist – designed for healthcare professionals who are not specialists in diabetes or related conditions, and who may work in a Primary Care setting.

  • SPEC Icon Square

    Specialist – these sessions are designed for specialists in diabetes and related conditions. Sessions may also be appropriate for Primary Care specialists or leads in diabetes and related conditions.

*NB – These are advisory labels so please read the session description and learning outcomes carefully to ensure the session is right for you

Please select the stream you wish to view

09:00 - 09:50

Keynote Panel: The simplicity of type 2 diabetes – and what to do about it

This keynote session will present and discuss the new understanding of type 2 diabetes and what this means for everyday clinical practice. It is now possible to describe what predisposes a person to type 2 diabetes and separately to identify what determines whether or not the disease develops. That basic understanding led to the Counterpoint study which was the first to show why and how type 2 diabetes can be reversed to normal by substantial weight loss. Further studies showed the importance of duration of type 2 diabetes, with very high possibility of remission in newly diagnosed diabetes falling to around 50% up to 10 year of type 2 diabetes. The practicality of achieving 10-15kg weight loss in Primary Care was tested in DiRECT, and many sound pointers to wise management were derived. Visitors will also here from Mark Olejnik, a person diagnosed with Type 2 diabetes and who has since achieved Remission independently – without any outside intervention. Mark will give visitor’s insight into the importance of diet, exercise, and a support structure in his journey to T2 Remission.

Person who has achieved Remission without outside intervention
Consultant in Diabetes & Endocrinology, Chairman, Pinderfields Hospital, Mid Yorkshire NHS Trust in Wakefield, West Yorkshire, ABCD
Professor of Medicine and Metabolism and Director, Newcastle Magnetic Resonance Centre
10:00 - 10:40

Classifying diabetes

This session will cover the latest on the tools available to help classify diabetes, pitfalls in diabetes classification and interactive case studies. Learning outcomes: Understand the benefits of correct classification Understanding the limitations of clinical-based diabetes classification Understand how biomarkers can facilitate classification Understand the limitations of biomarkers in this context


Consultant Physician in Diabetes, Metabolism & Laboratory Medicine, Imperial College London
10:40 - 11:50

NETWORKING & EXHIBITION

11:50 - 12:30

When is the right time to start GLP-1 RA treatment in people living with type 2 diabetes?

This is a sponsored symposium organised by Novo NordiskNovo Nordisk products will be discussed and prescribing information and adverse event reporting will be available at the meeting Many people living with type 2 diabetes are escalated from oral therapies to basal insulin. Approximately 87% of patients starting on basal insulin skipped the GLP-1 RA* class…

*This session has been organised and funded by Novo Nordisk

Diabetes Specialist Nurse, Community Diabetes Specialist Team, CNWL – Central and North West London NHS Foundation Trust
12:40 - 13:20

One organ plays two tunes – how is your pancreas today?

The pancreas has two vital jobs – producing insulin and digestive enzymes, but what happens if one of these functions stops working… this session looks at the relationship between the endocine and exocrine function of the pancreas and the link between diabetes and exocrine insufficiency. Learning outcomes: The relationship between the endocrine and exocrine pancreas…

*This session is organised and remunerated by Mylan

Consultant Physician, Endocrinology & Diabetes, Leeds Teaching Hospitals, NHS Trust
13:20 - 15:00

NETWORKING & EXHIBITION

15:00 - 15:50

The Live Debate: What is the best way to identify the ‘missing million’ undiagnosed people living with T2 diabetes?

The DPC2019 Live Debate will shine a light on, and bring attention to, the ‘missing million’ or so people who are living with type 2 diabetes in the UK but are undiagnosed.

Speaker Details TBC

16:00 - 16:40

Panel: Individualising our approach to diabetes support and education


Ben McGough
Workstream Lead – Digital, NHS Diabetes Programme, Public Health England (PHE)
Director, DESMOND, Leicester Diabetes Centre
DWELL Programme Lead, Medway Community Healthcare
10:00 - 10:40

The LTP – Reducing the burden on hospitals and refocusing Primary and Community care

We would like to share the experience of enacting and maintaining transformational change within Specialist Diabetes services along with the outcomes achieved for people with Diabetes and our Health Economies. We would like to share our focus on the use of Information Technology, communication, education, commissioning and integration of care in multiprofessional clinical practice. We…


Consultant Endocrinologist - Diabetes Care for You, Clinical Lead for Diabetes, NHS England & NHS Improvement, South East Clinical Networks
Dr Kate Fayers
Consultant Diabetologist, West Hampshire Community Diabetes Service
10:40 - 11:50

NETWORKING & EXHIBITION

11:50 - 12:30

Panel: LTP & The Diabetes Specialist Nursing Workforce

The overall aim of conducting the Diabetes Specialist Nurse (DSN) Audit was to ascertain how many DSNs were employed within NHS England. This presentation will discuss the background behind such an audit being undertaken. It will then go on to reveal the results of the audit and then open to a panel discussion as to…


Nurse Consultant – Diabetes, Medicus Health Partners, Co-Chair, TREND-UK and Chair Injection Technique Matters Initiative
Joint Regional Chief Nurse and Clinical Quality Director, NHS England and NHS Improvement, London
12:40 - 13:20

Why, Who, What, Where, When and How to use biosimilar insulins

NHS spending nearly DOUBLES to almost a billion in a decade – nearly one third is spent on Insulins. Biosimilars are comparatively less costly options – do they offer similar efficacy and safety? What are the cost implications? This session will uncover myths and facts about biosimilar insulins. Learning outcomes: Understand what biosimilar insulins are….

*This session is organised and remunerated by Mylan

Specialist pharmacist, North Bristol NHS Trust
Senior Clinical Pharmacist Diabetes and Endocrinology, County Durham and Darlington NHS Foundation Trust
13:20 - 15:00

NETWORKING & EXHIBITION

16:00 - 16:40

Panel: Deprescribing for cost saving in diabetes care


Medical Director, The Diabetes Reversal Company
Principal Clinical Teaching Fellow, Diabetes Warwick
10:00 - 10:40

Digital innovation in diabetes

Digital technologies offer new opportunities to improve patient experience, and deliver services in a more efficient way reducing the burden on clinicians and the public. The NHS Diabetes Programme has initiated this digital work stream to ensure that the programme can harness these opportunities. Recognising that face to face interventions do not always work for…


Ben McGough
Workstream Lead – Digital, NHS Diabetes Programme, Public Health England (PHE)
10:40 - 11:50

NETWORKING & EXHIBITION

11:50 - 12:30

Diabetes prevention in high-risk ethnic groups

The talk will focus on the risk of type 2 diabetes in minority ethnic groups, particularly South Asians, and how this can be addressed through lifestyle interventions. In particular, how lifestyle can be optimised for ethnic minorities. Learning outcomes: Difference in risk factors between ethnic groups, with a focus on South Asians Differences in lifestyle…


Tom Yates
Professor of Physical Activity, Sedentary Behaviour and Health, Diabetes Research Centre, University of Leicester
12:40 - 13:20

Socioeconomic, psychosocial & environmental challenges of introducing lifestyle interventions

This interactive session will explore the challenges to initiating and maintaining lifestyle change interventions, and encourage participants to consider how they as health professionals can support individuals in overcoming them. Learning outcomes: How making changes to lifestyle habits is by definition abnormal How the food and marketing environments in which we live can sabotage attempts…


Independent Consultant & Author
13:20 - 15:00

NETWORKING & EXHIBITION

15:00 - 15:50

Understanding weight gain and the risks associated with it

How we gain weight is a controversial topic, there are likely a wealth of psychological and physiological mechanisms that divert away from homeostasis. This combined with the arguably obesogenic environment we live in can lead to significant weight gain. Learning outcomes: The psychology behind weight gain The physiology behind weight gain Environmental factors that contribute…


Matthew Whitaker
Digital Health Lead, Xpert Health
16:00 - 16:40

Low calorie diets to treat obesity and Type 2 diabetes

The NHS Long Term Plan announced that hundreds of thousands of people will receive NHS help to battle obesity and Type 2 diabetes.Medical research has shown that some people with type 2 diabetes can achieve remission through adoption of a low-calorie diet which allowed nearly half of patients to stop taking anti-diabetic drugs and still…


Dr Chirag Bakhai
GP, Vice-Chair of Luton CCG, Primary Care Advisor to the NHS Diabetes Programme, NHS England and NHS Improvement
Professor of Medicine and Metabolism and Director, Newcastle Magnetic Resonance Centre
Senior Research Fellow, University of Oxford
10:00 - 10:40

Living Beyond Diabetes


Person with Diabetes (PWD)
Diabetes Specialist Nurse, Raigmore Hospital
10:40 - 11:50

NETWORKING & EXHIBITION

11:50 - 12:30

The National Diabetes Audit: learning from measurement

The NDA now spans Diabetes Prevention through Routine Preventive Care for people with Type 1 and Type 2 diabetes, Specialist Care for people with Type 1 diabetes, inpatients, pregnant women and foot disease to all the long term complications. It includes more than 98% of people with diagnosed diabetes in England and Wales. This presentation…


Clinical Lead, National Diabetes Audit, DUK, NHS Digital
12:40 - 13:20

CGM 101


Speaker Details TBC

13:20 - 15:00

NETWORKING & EXHIBITION

15:00 - 15:50

DIY artificial pancreas systems in the real world

This talk will build on previous discussions on DIY APS. It will introduce DIY APS as a unique example of a technology driven, patient led care delivery model that can offer sustainable metabolic and psychological improvements in T1 care. It will summarise current evidence for their use and reasons for their use. The talk will…


Consultant Physician in Diabetes & Endocrinology and Honorary Senior Clinical Lecturer, Guy’s & St Thomas’ NHS Foundation Trust and King’s College London
Person with diabetes
'Diabetes Dad'
10:00 - 10:40
10:40 - 11:50

NETWORKING & EXHIBITION

11:50 - 12:30

Treatment & medication advice for T2 children (practical)

It is over 17 years since the randomised controlled trial of metformin showed efficacy in childhood type 2 diabetes. Since that time, despite much investment in paediatric investigation plans, very few interventional clinical trials have reported. This presentation reviews the evidence for childhood type 2 diabetes being different to adult type 2 diabetes. Childhood type…


Leonard Parsons Professor of Paediatrics, University of Birmingham
12:40 - 13:20

Poole YPDS – Supporting young people between 15 and 25 years old

In 2012, paediatric Best Practice Tariff funding was used to expand the paediatric diabetes service in Poole, Dorset, to set up a specific service for patients aged 15–23 years who were transitioning to adult diabetes care. The resulting Young People’s Diabetes Service (YPDS) has undergone continuous development since then, based on feedback from the children’s…


Jo Dalton
Diabetes Specialist Nurse – Transition, Young People’s Diabetes Service (YPDS), Poole Hospital Foundation Trust
13:20 - 15:00

NETWORKING & EXHIBITION

15:00 - 15:50
10:00 - 10:40

What you need to know about starting insulin: the basics

This session explains why people with type 2 diabetes may require insulin therapy. It describes the main areas to address when supporting someone starting a once-daily insulin regimen. Learning points: Identify people who require insulin treatment Describe the commonly used insulins used in a once-daily regimen Describe correct injection technique and equipment required List the…


Independent Nurse Consultant & Co-Chair, TREND-UK & ITM
10:40 - 11:50

NETWORKING & EXHIBITION

11:50 - 12:30

Diabetes & dementia

Self-management is a crucial element to the successful management of living with diabetes. The combination of dementia and diabetes therefore poses a considerable challenge to safety and quality of life. This session explores the implications of living with both conditions and describes some areas to consider when supporting individuals living with diabetes and dementia, and…


Independent Nurse Consultant & Co-Chair, TREND-UK & ITM
12:40 - 13:30

Injection Technique Matters with Lipohypertrophy ‘Live’ Demonstration

This presentation will explore research that has confirmed that people who use injectable therapies for diabetes can be adversely affected if the correct injected technique is not used at each injection. It will give information on the correct injection technique to be teaching those who need injectable therapies to achieve optimum benefit from their therapy….


Nurse Consultant – Diabetes, Medicus Health Partners, Co-Chair, TREND-UK and Chair Injection Technique Matters Initiative
13:20 - 15:00

NETWORKING & EXHIBITION

15:00 - 15:50

Diabetic ketoacidosis and hyperosmolar hyperglycaemic state: 2 different sides of the same coin

Diabetic ketoacidosis and Hyperosmolar Hyperglycaemic State are life-threatening conditions that are characterised as hyperglycaemic emergencies. There the similarity ends. This session aims to inform, educate, and discuss the different groups affected by these very different conditions; and to assist health care professionals in the prevention, recognition, and early treatment needed to prevent hospital admission in…


Nurse Consultant & Associate Professor, Co-Chair, Leicester Diabetes Centre, Leicester University Hospitals, TREND-UK & ITM
16:00 - 16:40

Insulin Masterclass – Insulin regimens: one size doesn’t fit all

The discovery of insulin was almost a century ago; emerging from these humble but life-changing times we now have more than 30 insulin products available to choose from when recommending for people living with diabetes. This combined with different modes of actions, different devices, different concentration of insulin can add to the confusion. The National…


Nurse Consultant & Associate Professor, Co-Chair, Leicester Diabetes Centre, Leicester University Hospitals, TREND-UK & ITM
10:00 - 10:40

The importance and challenges of transition

The session will include some pertinent data giving context around why this area is important. Some general teaching around the physiology of the adolescent brain and some coal face tips that practitioners can deploy. Learning outcomes: Definition of transition Why it matters Why it’s so difficult Some practical tips


Consultant in Diabetes & Endocrinology and General Medicine, Association of British Clinical Diabetologists (ABCD)
10:40 - 11:50

NETWORKING & EXHIBITION

11:50 - 12:30

T1 Pregnancy & CGM – what is the optimum service model?

The aim of the session is to share best practice for starting, managing and optimising real-time Continuous Glucose Monitoring (RT-CGM) and intermittent/flash glucose monitoring in pregnancy. It will support antenatal health care staff to deliver safe, effective and high quality care of pregnant women using CGM. Learning outcomes: Getting started: CGM set up in pregnancy…


Helen Murphy
Professor of Medicine (Diabetes and Antenatal Care), Group 1 Lead – Cardiometabolic and Gut Health, Norwich Medical School
12:40 - 13:20

Experience from established integrated care services

Discussion of models of integrated diabetes care. Learning outcomes: Understand the principles and opportunities for integrated care in diabetes  


Consultant in Diabetes & Endocrinology, Chairman, Pinderfields Hospital, Mid Yorkshire NHS Trust in Wakefield, West Yorkshire, ABCD
Strategic Lead Consultant, Royal Free Hospital, London
13:20 - 15:00

NETWORKING & EXHIBITION

15:00 - 15:50

Exercise & Sport T1 DM

This session will explore how we can support adult patients with T1D to exercise. It will explore aspects relating to safe starting glucose values and glucose values that are a contraindication to exercise. We will also discuss the effect of different exercises on glucose values and how these can be managed. We will discuss the…


Reader/Consultant in Medicine, Birmingham University
16:00 - 16:40

T1 Tech Pathway

Dr Choudhary is the chair of the Diabetes Technology Network – UK, which is a part of ABCD. He was involved with multiple stakeholders including patient charities and NHSE in developing a cohesive type 1 technology pathway that tries to pull together individual guidance on different technologies into a pathway that can be used by…


Dr Pratik Choudhary
Senior Lecturer and Consultant in Diabetes, Kings College Hospital
10:00 - 10:40

Pregnancy in Primary Care: diabetes risk factors & assessment


Susan Down
Nurse Consultant Diabetes, Somerset Primary Care Trust and Yeovil District Hospital NHS Foundation Trust
10:50 - 11:10

Ozempic® ▼ (semaglutide) in clinical practice

Learning Objectives: To discuss and understand the results of SUSTAIN 7: Ozempic® versus dulaglutide in adults with type 2 diabetes To discuss and understand the results of SUSTAIN 6: cardiovascular outcomes of Ozempic® versus standard of care in adults with type 2 diabetes Prescribing information and adverse event reporting will be available at the meeting….

*This session has been organised and funded by Novo Nordisk

Regional Medical Advisor, Novo Nordisk UK
11:20 - 11:40

Introducing Better Living – empowering people to take charge of their Type 2 diabetes

An introduction to the Better Living materials which help empower people to take charge of their Type 2 diabetes. Learning outcomes: To see what Better Living has on offer for people living with Type 2 diabetes

*This session has been organised and funded by Takeda UK Ltd

Medical Science Liaison, Diabetes, Takeda UK Ltd
11:50 - 12:30

The importance of a person-centred and evidence-based approach to the management of type 2 diabetes

Kevin Fernando (GPwSI Diabetes & Medical Education, North Berwick Health Centre) and Su Down (Nurse Consultant Diabetes, Somerset Partnership NHS Foundation Trust) will guide you through an interactive panel discussion on why an individualised approach is important for the management of the person with T2DM based on their individual clinical characteristics. Learning outcomes (Objectives): Attendees…

This promotional symposium is organised and fully funded by MSD.

GP Partner & Medical Education & Scottish Lead, North Berwick Health Centre, GPwSI Diabetes, Primary Care Diabetes Society
Susan Down
Nurse Consultant Diabetes, Somerset Primary Care Trust and Yeovil District Hospital NHS Foundation Trust
12:40 - 13:20

Practical advice and tips for older people with diabetes: 3 avenues of assessment & management

What is frailty and how does it affect the management of diabetes – practical tips and case studies. Learning points: Understand the targets for these groups of patients Assessment of frailty Practical management of frailty and diabetes


Senior In-Patient Diabetes Specialist Nurse (William Harvey Hospital), Consultant Nurse (Project Lead), Ashford CCG Housebound Project & Mocketts Wood Surgery
AMAR PUTTANNA
Consultant in Diabetes and Endocrinology, Good Hope Hospital, University Hospitals Birmingham NHS Foundation Trust
13:30 - 13:50

Frailty in the elderly – managing the use of insulin

To understand the changes needed in clinical practice based on new elderly and best practice care guidelines Discuss personalised glycaemic targets in frail and older people and the risks of hypoglycaemia How to assess for frailty and identify those at risk. What treatment strategies can be used and when is it appropriate to de-escalate therapies

*This session is organised and remunerated by Mylan

Susan Down
Nurse Consultant Diabetes, Somerset Primary Care Trust and Yeovil District Hospital NHS Foundation Trust
14:30 - 14:50

Introducing the new Omnipod DASH™ Insulin Management System

This session will provide introduction to Insulet and a practical overview of the new Omnipod DASH™ System. Learning outcomes: Understand the benefits of the Omnipod DASH™ System See a demonstration of the Omnipod DASH™ System Understand the data behind the benefits Overview of the Omnipod® Support Programme INS-ODS-10-2019-00026v1


Healthcare Professionals who manage people on insulin pump therapy
15:00 - 15:50
16:00 - 16:40

MDI – Practical Advice for MDI & BG monitoring

To explore the practicalities of blood glucose monitoring for patients with diabetes using multiple daily injections. Why and when we should ask our patients to do it. Explore the data we can get from it and how this can not always be positive. Consider the range of blood glucose meters and the pitfalls of using…


Community Diabetes Specialist Nurse, Southampton City, Solent NHS Trust

Our site is intended for UK Healthcare Professionals

Are you a UK Healthcare Professional?

We’re sending you to our partner charity’s site. 

DRWF provide information and support for people with diabetes and their friends & families

Scroll To Top